baber/WOPTO huggingface dataset:
Patent DE-69508249-D1 (DE)
Inventor: TILMANS ETIENNE
IPC: A47C27/08
Filed: 1995-10-27
Granted: 1999-04-15
Abstract: The invention relates to a soft edging for a water bed the edging of which being formed by a hollow profile (5), two sides, (6, respectively 7), directed towards each other and the uppermost of these sides, (6), determines an inwardly and downwardly directed surface onto which a foam rail (19) rests, while the lowermost (7) determines with the bed plate (1) a continuous hollow space wherein a wedging-shaped component (20), which is connected to said foam rail (19) by a flexible material, such as a strip of textile (21), can be kept clamped. <IMAGE>
Patent DE-69513991-D1 (DE)
Inventor: HANSEN ANDREW
IPC: C10B53/00
Filed: 1995-09-19
Granted: 2000-01-20
Abstract: A system for pyrolysis of hydrocarbon constituents of waste material including a treatment unit featuring a retort with a ellipsoidal cross-section forming a first retort half and a second retort half, the material to be treated being selectively deposited in only one half of the retort at a time during any given period of system operation, to avoid abrasion and wear of the half not in use, thus effectively doubling the life of the retort component. Another feature of a treatment unit according to the invention is a heat reclamation arrangement that introduces gases that have first been combusted to supply heat energy to the retort through a conduit directly into the interior of the retort, to improve the efficiency with which pyrolysis takes place. Further, the treatment unit has an exhaust and cleaning arrangement to render gases produced during pyrolysis substantially free of pollutants such that the gases can be vented to the atmosphere. The exhaust and cleaning arrangement is characterized by a plurality of selectively detachable gas injection tubes, which provide fuel for thermal oxidation of the gases. Each injection tube can be removed for cleaning independently of any other injection tube, and removal can be accomplished without disrupting operation of the system. Still another feature of the treatment unit of the invention is the redundancy and high-temperature resistance of the seal between the retort and other components of the unit.
Patent DE-69518491-D1 (DE)
Inventor: PIVETEAU PIERRE
IPC: E04F13/08
Filed: 1995-11-15
Granted: 2000-09-28
Abstract: The thin facing plates (1A,1B) are assembled and fixed onto a support (3). One facing plate (1A) has on its section a continuous tongue ((8) which partially penetrates into a rebate (9) in the section of the complementary facing plate (1B). An assembly groove (10) is provided in the extension of the rebate. These facing plates are fitted with an assembly section (2), which they conceal, to the support. The assembly section comprises a base plate which is fixed to the support and a facing plates' retaining leg (6). This retaining leg, parallel to the base plate and joined to it by a web, is inserted in the assembled position of the facing plates partially in the assembly groove of one of the facing plates (1B).
Patent DE-69522931-D1 (DE)
Title: Interaktiv compact-disc system
Inventor: MCRAE FINLAY
IPC: G11B19/02
Filed: 1995-03-23
Granted: 2001-10-31
Abstract: Method of controlling the playing of a compact disc on a compact disc player, characterized in that the method comprises the following steps:   reading software instructions indicating the location where the compact disc is to be played from the compact disc,     and in response to a request that the compact disc be played,   operating the compact disc player in accordance with a control program to compare a code provided by the compact disc player with the software instructions to correspondingly at least partly enable or disable the playing of the compact disc.   Compact disc player for controlling the playing of a compact disc on the compact disc player and a compact disc for use in the compact disc player.
Patent DE-69530986-D1 (DE)
Inventor: EDGSON RAYMOND
IPC: G01N33/493
Filed: 1995-07-28
Granted: 2003-07-10
Abstract: Method and device for measuring the concentration or urea or a similar substance, in a composite solution, particularly a dialysis solution, by catalytic decomposition of urea by urease. The differential conductivity of the reacted and unreacted solution is measured and is proportional to the urea concentration. A sample solution is taken out from the composite solution by a pump (6) and divided into two branches. The first branch passes a reactor column (10), a temperature equalizing coil (71) and a first measurement cell (7a), and the second branch passes a delay vessel (22), a temperature equalizing coil (72) and a second measurement cell (7b). <IMAGE>
Patent DE-69532013-D1 (DE)
Inventor: COOPER ROBIN DAVID GREY
IPC: A61P31/00
Filed: 1995-01-25
Granted: 2003-12-04
Abstract: A new glycopeptide molecule is inserted into the antibiotic group and both components are mixed with a standard pharmaceutical carrier.
Patent DE-69532686-D1 (DE)
Inventor: ST GOAR G
IPC: A61M25/14
Filed: 1995-11-21
Granted: 2004-04-15
Abstract: A catheter system is provided for accessing the coronary ostia transluminally from a peripheral arterial access site, such as the femoral artery, and for inducing cardioplegic arrest by direct infusion of cardioplegic solution into the coronary arteries. In a first embodiment, the catheter system is in the form of a single perfusion catheter with multiple distal branches for engaging the coronary ostia. In a second embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single arterial cannula. In a third embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single guiding catheter. In a fourth embodiment, multiple catheters are delivered to the coronary ostia through a single guiding catheter which has distal exit ports that are arranged to direct the perfusion catheters into the coronary ostia. In each embodiment, the catheters are equipped with an occlusion means at the distal end of the catheter for closing the coronary ostia and isolating the coronary arteries from the systemic blood flow. The occlusion means can take the form of an inflatable occlusion balloon cuff, a tapered occlusion device or an O-ring encircling the distal end of the catheter. An optional ventricular venting catheter can be included in the system for venting blood and fluids from the left ventricle of the heart. The catheter system is combined with a femoral-to-femoral cardiopulmonary bypass system to provide a system for cardioplegic arrest and total cardiopulmonary support during minimally invasive cardiac surgical procedures.
Patent DE-69534659-D1 (DE)
Inventor: TING BENJAMIN S
IPC: H03K19/177
Filed: 1995-04-14
Granted: 2006-01-05
Abstract: An FPGA is comprised of a number of cells which perform logical functions on input signals. Programmable intraconnections provide connectability between each output of a cell belonging to a logical cluster to at least one input of each of the other cells belonging to that logical cluster. A set of programmable block connectors are used to provide connectability between logical clusters of cells and accessibility to the hierarchical routing network. A uniformly distributed first layer of routing network lines is sued to provide connections amongst sets of block connectors. A uniformly distributed second layer of routing network lines is implemented to provide connectability between different first layers of routing network lines. Switching networks are used to provide connectability between the block connectors and routing network lines corresponding to the first layer. Other switching networks provide connectability between the routing network lines corresponding to the first layer to routing network lines corresponding to the second layer. Additional uniformly distributed layers of routing network lines are implemented to provide connectability between different prior layers of routing network lines.
Patent DE-69603703-D1 (DE)
Inventor: JOURDE BERNARD
IPC: D04H18/02
Filed: 1996-01-12
Granted: 1999-09-16
Abstract: PCT No. PCT/FR96/00050 Sec. 371 Date Jul. 11, 1997 Sec. 102(e) Date Jul. 11, 1997 PCT Filed Jan. 12, 1996 PCT Pub. No. WO96/21761 PCT Pub. Date Jul. 18, 1996A brush conveyor, in particular for a velvet needle loom, includes an assembly of adjacent brushes forming a conveying plane and moving in a predetermined conveying direction. Each brush includes a body that is substantially elongated along a main axis, and each lower brush surface includes means for connecting the brush to a mechanical drive device while the upper brush surface has holes for receiving tufts of bristles. The brushes are arranged within the conveyor in such a way that their main axes are parallel to each other and lie at a predetermined angle to a transverse direction which is perpendicular to the conveying direction. The conveyor may be used in needle looms for making nonwoven articles.
Patent DE-69619102-D1 (DE)
Inventor: LUNDGREN GOERAN
IPC: B27N3/10
Filed: 1996-03-11
Granted: 2002-03-21
Abstract: PCT No. PCT/SE96/00310 Sec. 371 Date Oct. 7, 1997 Sec. 102(e) Date Oct. 7, 1997 PCT Filed Mar. 11, 1996 PCT Pub. No. WO96/31327 PCT Pub. Date Oct. 10, 1996Methods for the continuous manufacture of board from lignocellulose-containing material are disclosed including disintegrating the lignocellulose material into particles or fibers, drying, coating with glue, forming the glued board into a mat, heating the mat with steam, compressing the heated mat to a predetermined thickness approximately equal to the final desired thickness of the board, and pressing the compressed mat into the board.
Patent DE-69621518-D1 (DE)
Inventor: SCALLAN ALEC
IPC: A23B4/06
Filed: 1996-05-16
Granted: 2002-07-11
Abstract: Fresh whole prawns are dipped in a solution of sodium metabisulphite and then sorted and graded. The prawns are then arranged in an open-topped container in a generally linear pattern with their shells uppermost. The graded prawns are blast frozen and a first glazing liquid is applied to achieve a weight ratio of glazing liquid to prawns of approximately 1:8. After freezing for a period of at least 8 hours, the frozen prawns are glazed a second time by spraying a second glazing liquid onto the surface of the frozen prawns. The glazing liquids in one or both glazing steps may contain a polyphosphate based glazing compound.
Patent DE-69622989-D1 (DE)
Inventor: TOCQUE BRUNO
IPC: A61K33/243
Filed: 1996-01-12
Granted: 2002-09-19
Abstract: A medicinal combination of one or more nucleic acids that at least partially inhibit oncogenic cell signalling pathways, and a therapeutic anticancer agent, for use simultaneous, separate or over a period of time to treat hyperproliferative diseases.
Patent DE-69625329-D1 (DE)
Inventor: KASTENHOFER GERHARD
IPC: A61M29/02
Filed: 1996-04-26
Granted: 2003-01-23
Abstract: The catheter comprises a catheter tube 1 formed of two superposed tubular layers of materials 2 and 3 which differ from one another. A tubular mediator layer means 4 is arranged between layers 2 and 3 to provide an adhesive anchorage for layers 2 and 3. The tubular mediator layer means is made of two superposed layers 27 and 28. <IMAGE>
Patent DE-69628021-D1 (DE)
Inventor: JARVIS C
IPC: G02C7/02
Filed: 1996-07-03
Granted: 2003-06-12
Abstract: An impact resistant face shield that includes a single formed arcuate lens portion that, in a first orientation, has a first curvature extending in a horizontal direction and a second curvature extending in a vertical direction. The lens portion has a top portion and a bottom portion that extends relatively inwardly towards the face of the wearer relative to an intermediate portion disposed between the top and bottom portions. Each curvature of the lens defines an arc of a circle having a substantially uniform radius to produce nominal levels of distortion, thereby reducing the prism effects created by the lens, and providing an optically corrected viewing window.
Patent DE-69630317-D1 (DE)
Inventor: VAN HOECK JAMES
IPC: A61B17/58
Filed: 1996-05-28
Granted: 2003-11-13
Abstract: One embodiment of a spinal fixation system 10 including a pair of longitudinal members 11, 12 positionable adjacent the spine, means for engaging longitudinal members to the spine 13, 14, a pair of wedge members 16 each having a bearing surface 38 configured to bear on a longitudinal member 11, 12, and a connector 20 configured to span a distance between the longitudinal members 11, 12. The connector 20 includes a pair of engaging members 25, 26 each having a fixation surface 33 and a connecting surface 30, and a bridge member 21 attached to the connecting surfaces 30. The engaging members 25, 26 each define a thru-hole 35 for receiving one of the wedge members 16. The thru-holes 35 are aligned so that when one of the wedge members 16 is advanced through the thru-hole 35, the bearing surface 38 will bear on a corresponding longitudinal member 11, 12 to force the longitudinal member 11, 12 into contact with the fixation surface 33 and engage the longitudinal member 11, 12 to the connector 20.
Patent DE-69631883-D1 (DE)
Inventor: DELESIE PATRICK
IPC: A47C23/06
Filed: 1996-06-06
Granted: 2004-04-22
Abstract: PCT No. PCT/BE96/00055 Sec. 371 Date Mar. 25, 1998 Sec. 102(e) Date Mar. 25, 1998 PCT Filed Jun. 6, 1996 PCT Pub. No. WO96/39067 PCT Pub. Date Dec. 12, 1996A relaxation device for furniture, particularly for an armchair of relaxing chair, includes body support flats (11, 12, 13; 101; 201) which are each formed of interconnected elongated support members (3) extending parallel to each other and transversally to a longitudinal axis of the device (Z), a frame (2) and means (23, 43) for coupling the above support flats (11, 12, 13; 101, 201) to the frame (2), characterized in that each set of elongated support members (3) is mounted by means of a multiple action suspension system (S1, S2) which is formed of a first stage suspension unit wherein each pair of adjacent elongated support members (3', 3'') is externally coupled by means of primary intermediate suspension parts (31), and at least one additional second stage suspension unit wherein each pair of adjacent primary intermediate suspension parts (31', 31'') is externally coupled by secondary suspension parts (33; 32', 32'') which are directly (23) or indirectly (23, 33, 24) connected to the frame (2), so that the elongated support members (3) are mutually movable in two modes and can move from an unloaded state (A) to a loaded state (B) with the superimposed undulatory motion of said members (3).
Patent DE-69635029-D1 (DE)
Inventor: TANAKA NORIAKI
IPC: A61M1/14
Filed: 1996-10-25
Granted: 2005-09-08
Abstract: This invention provides a method for reprocessing a dialyzer for hemodialysis, the method comprising the steps of rinsing the dialyzer with water and cleaning it with electrolyzed strongly acidic water, or the steps of rinsing the dialyzer with water, cleaning it with electrolyzed strongly alkaline water, rinsing it with water and cleaning it with electrolyzed strongly acidic water, as well as a reprocessing apparatus for carrying out the reprocessing method. <IMAGE>
Patent DE-69636890-D1 (DE)
Inventor: FREEMAN J
IPC: C12N15/85
Filed: 1996-06-06
Granted: 2007-03-22
Abstract: Nucleic acids encoding CTLA4/CD28 ligands which costimulate T cell activation are disclosed. In one embodiment, the nucleic acid has a sequence which encodes a fusion protein consisting of at least part of the B lymphocyte antigen, B7-2, fused to one or more constant domains of immunoglobulin heavy chain. Preferably, the nucleic acid is a DNA molecule comprising at least a portion of a nucleotide sequence shown in Figure 8, SEQ ID NO:1 or Figure 14, SEQ ID NO:23. The nucleic acid sequences of the invention can be integrated into various expression vectors, which in turn direct the synthesis of the corresponding proteins or peptides in a variety of hosts, particularly eukaryotic cells, such as mammalian and insect cell culture. Also disclosed are host cells transformed to produce proteins or peptides encoded by the nucleic acid sequences of the invention and isolated proteins and peptides which comprise at least a portion of a novel B lymphocyte antigen. Proteins and peptides described herein can be administered to subjects to enhance or suppress T cell-mediated immune responses.
Patent DE-69700213-D1 (DE)
Inventor: WALTER DENIS
IPC: E04B7/10
Filed: 1997-10-13
Granted: 1999-06-24
Abstract: The flexible building cover has its roof part defined by a metal or three dimensional composite frame constituted by a base structure. This structure comprises two parallel beams (5,6) from where diagonals (9,9A,9B,9C) extend. The two beams are defined by a grooved section receiving a beading fitting the two longitudinal edges (13,14) of one or more covers of double curvature (7). The section can be provided with means (15) for fixing the ends (16) of the diagonals or cross members (8).
Patent DE-69702360-D1 (DE)
Inventor: BREULET JACQUES
IPC: C08F4/24
Filed: 1997-03-20
Granted: 2000-08-03
Abstract: Statistical terpolymers comprising 98.2-99.8 (98.8-99.3)mol. % units derived from ethylene, 0.1-0.3 mol. % units derived from 1-butene and 0.1-1.5 (0.6-0.9) mol % units derived from 1- hexene, and having a density of 936-943 (938-940) kg/m<3>.
Patent DE-69708882-D1 (DE)
Inventor: HOLBROOK MARK BURTON
IPC: G01B15/02
Filed: 1997-08-11
Granted: 2002-01-17
Abstract: The thickness of a thin layer structure is monitored during deposition or etching. The structure is illuminated with a predetermined energy (visible or near visible light or x-ray) and a modified parameter of the illumination is measured, which may be reflection intensity, transmission intensity or polarisation. The detected signal is examined by shape recognition techniques using adaptive digital filters.
Patent DE-69713883-D1 (DE)
Inventor: BECKER T
IPC: C07K1/32
Filed: 1997-12-18
Granted: 2002-08-14
Abstract: A process for recovering a protein such as an enzyme from an aqueous solution using a lignosulfonate having a low degree of sulfonation. Also disclosed are protein/lignosulfonate complexes and use of these in granules.
Patent DE-69722812-D1 (DE)
Inventor: VANDEN BRANDE PIERRE
IPC: H01J37/34
Filed: 1997-12-09
Granted: 2003-07-17
Abstract: PCT No. PCT/BE97/00133 Sec. 371 Date Jun. 8, 1999 Sec. 102(e) Date Jun. 8, 1999 PCT Filed Dec. 9, 1997 PCT Pub. No. WO98/26108 PCT Pub. Date Jun. 18, 1998Disclosed is a process for forming a coating on a substrate (2,2') by cathode sputtering, comprising the coating of substrate surfaces (2,2') which have been transferred to a cathode sputtering chamber (1). The substrates vary in width and have a predetermined maximum width. The process involves the use of a target (3) whose surface (4) has an invariable length corresponding approximately to said maximum substrate width. A shift takes place, in accordance with the width of the substrate being coated, between the surface (4) of the target and the substrate surface to be coated, so that the entire surface of the target remains more or less constantly in front of the surface to be coated during the cathode sputtering process.
Patent DE-69729662-D1 (DE)
Inventor: LANDRY ALAIN
IPC: A61C11/08
Filed: 1997-12-16
Granted: 2004-07-29
Abstract: The adjustable mounting device comprises two superposed plates in sliding relationship. One of the plates is pivotally connected to the articulator. A first mechanism is provided to selectively slide and lock in position one of the plates relative to the other while this other plate is provided with a second mechanism to selectively rotate and lock the device in position with reference to the dental articulator. This mounting device replaces one or both conventional fixed mounting plates in a dental articulator to provide adjustability between the lower and upper parts of the dental cast.
Patent DE-69730023-D1 (DE)
Inventor: MILDER L
IPC: A01N59/16
Filed: 1997-04-16
Granted: 2004-09-02
Abstract: An iontophoretic material is provided that uses controlled electrical current derived from two dissimilar galvanic materials to drive oligodynamic metal ions into solution to kill microorganisms on and near the material. Iontophoretic structures or material associated with a medical device are partially or completely covered with one or more covering layers that alter physical, mechanical, chemical, or biological properties of the device and/or the iontophoretic material. In addition to being partially coated or completely enveloped by iontophoretic material or structures, all or a portion of a medical device can be integrated with, impregnated by, or fabricated from an iontophoretic material.
Patent DE-69737024-D1 (DE)
Title: Thermostabiles nukleinsäure-polymerase von thermococcus gorgonarius
Inventor: ANKENBAUER WALTRAUD
IPC: C12Q1/68
Filed: 1997-10-01
Granted: 2007-01-11
Abstract: A purified thermostable enzyme is derived form the thermophilic archaebacterium Thermococcus gorgonarius. The enzyme can be native or recombinant, retains approximately 90 % of its activity after incubation for two hours at 95 DEG C in the presence of stabilizing agents and possesses 3'-5' proofreading exonuclease activity. Thermostable DNA polymerases are useful in many recombinant DNA techniques, especially nucleic acid amplification by the polymerase chain reaction (PCR). <IMAGE>
Patent DE-69802514-D1 (DE)
Inventor: WILSON TONY
IPC: G01B11/24
Filed: 1998-04-03
Granted: 2001-12-20
Abstract: An object is illuminated by a light source, and a periodic pattern of transparent and non-transparent stripes is superimposed onto the object. At least three images are recorded at different spatial phases of the pattern by means of a microscope of shallow focal depth, and a three-dimensional image containing only in-focus detail is then derived from the recorded images.
Patent DE-69803670-D1 (DE)
Inventor: CLANCY JOSEPH
IPC: A61K9/32
Filed: 1998-07-30
Granted: 2002-03-14
Abstract: Controlled release oral pharmaceutical preparations are provided which comprise a therapeutically effective amount of tiagabine or a pharmaceutically acceptable salt thereof dispersed in a rate controlling polymeric matrix comprising at least one rate controlling polymer. The preparation can be formulated into oral dosage forms such as tablets or multiparticulates which provide therapeutically effective plasma levels of tiagabine for a period of at least 12 hours, preferably 24 hours or more. The preparation can provide tiagabine mean plasma concentrations equal to or greater than 50 % of the maximum plasma concentration for at least 10 hours, preferably 14 hours, most preferably 16 hours or more.
Patent DE-69805777-D1 (DE)
Inventor: HARMER ANDREW
IPC: B01J31/12
Filed: 1998-03-19
Granted: 2002-07-11
Abstract: This invention concerns a silylated porous microcomposite comprising a perfluorinated ion-exchange polymer entrapped within and highly dispersed throughout a network of inorganic oxide wherein the network and optionally the polymer have been modified with a silylating agent. These silylated microcomposites can be used in heterogeneous catalyst compositions for various chemical processes, such as in esterifications and acylations.
Patent DE-69807388-D1 (DE)
Inventor: TAMBORINI ARIBERTO
IPC: A47L9/24
Filed: 1998-02-26
Granted: 2002-10-02
Abstract: The present invention relates to a modular rigid extension tube (1) for floor, moquette, carpet and the like washing-sucking machines, characterized in that the tube comprises a tube body having, in the inside thereof, a sucking duct (2) and, on the outside thereof, a delivery duct (3), made in a single-piece with the sucking duct (2). The tube body is provided with sealing means (10,11,12,13) for tightly coupling it to an adjoining extension tube. <IMAGE>